These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8319521)

  • 61. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
    Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
    Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control.
    Tan CE; Chew LS; Tai ES; Chio LF; Lim HS; Loh LM; Shepherd J
    Atherosclerosis; 2001 Feb; 154(2):469-74. PubMed ID: 11166781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
    Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
    Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Ramadan fasting in type 2 diabetes mellitus].
    Bouguerra R; Jabrane J; Maâtki C; Ben Salem L; Hamzaoui J; El Kadhi A; Ben Rayana C; Ben Slama C
    Ann Endocrinol (Paris); 2006 Mar; 67(1):54-9. PubMed ID: 16596059
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].
    Tang W; Chen Y; Pan M; Chen L; Zhang L; Wang T; Zhang X; Zhang P; Zheng C; Yu B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):411-416. PubMed ID: 28440522
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
    Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
    Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease.
    Matsumoto K; Kizaki Y; Fukae S; Tomihira M; Sera Y; Ueki Y; Tominaga T; Miyake S
    Diabetes Res Clin Pract; 2001 Mar; 51(3):181-6. PubMed ID: 11269890
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of gender and type of diabetes on HDL-cholesterol.
    Merrin PK; Baynes C; Henderson A; Richmond B; Elkeles R
    Diabete Metab; 1994; 20(1):20-4. PubMed ID: 8056130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term comparison of three dietary prescriptions in the treatment of NIDDM.
    Milne RM; Mann JI; Chisholm AW; Williams SM
    Diabetes Care; 1994 Jan; 17(1):74-80. PubMed ID: 8112194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients.
    Beljic T; Miric M
    Acta Diabetol; 1994 Sep; 31(3):147-50. PubMed ID: 7827353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Felodipine Multicenter Prospective Study Group in Japan.
    Shionoiri H; Takizawa T; Ohyama Y; Ishii J; Katayama S; Nagasawa T; Kitamoto K; Nagasawa K; Hariya Y; Sato R
    Hypertension; 1994 Jan; 23(1 Suppl):I215-9. PubMed ID: 8282362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.
    Juntti-Berggren L; Pigon J; Karpe F; Hamsten A; Gutniak M; Vignati L; Efendic S
    Diabetes Care; 1996 Nov; 19(11):1200-6. PubMed ID: 8908380
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
    Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
    Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.
    Lehto S; Rönnemaa T; Haffner SM; Pyörälä K; Kallio V; Laakso M
    Diabetes; 1997 Aug; 46(8):1354-9. PubMed ID: 9231662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.